The Company also appoints Head of Marketing and Business Development in the USA in preparation for the early April 2021 product launch.
Vancouver, BC / December 9, 2020, / BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) reports that November sales orders (first full month) for the VINIA® nutraceutical e-commerce launch in Israel exceeded the earlier forecast and totaled $101,000 USD. Based on the first month’s demand for VINIA®, the company is increasing its quarterly sales forecast. VINIA®’s 4th Quarter, 2020 sales orders in Israel are now expected to be in the range of US$230,000-US$250,000. The 4th Quarter forecast represents a 380%-420% increase vs actual sales orders in Q4, 2019, and was driven by increases in total purchases, number of new customers, and the average value of first-time purchases. These critical metrics serve as good predictors for the way customers perceive the quality of VINIA® and its functional advantages. They also provide strong proof of the economics of the company’s B2C strategy.
“This first month of our Israeli e-commerce program has been a strong start and represents an important step toward our B2C commercialization goals.” commented Ilan Sobel, CEO of BioHarvest. “We will continue to refine our Israeli e-commerce VINIA® program, and the next big step in our Growth Plan will be bringing VINIA® to the United States. We are working towards an early April 2021, e-commerce launch in the US, and are building out the North American team that will execute our entry into the world’s largest nutraceutical market. Such developments further support our expectation for the Nutraceuticals vertical across all channels to break even in 2021 and for the entire company to break even in 2022.”
As part of the readiness for the US launch, the Company is pleased to announce it has hired Yael Morowati to lead all US Marketing and Business Development activities. Yael is a highly talented and experienced business leader who brings significant and relevant experience to strengthen the company’s sales and marketing capabilities. Yael has extensive experience with major Health & Wellness and Beauty related brands in the USA and played a critical role in building successful brands such as “MAJESTIC PURE” and “LOVING NATURALS” in her capacity as Chief Marketing Officer.
In her capacity as Head of Marketing and Business Development for the USA, Yael will be based in Florida and will report directly to the CEO. She joins Nat Averill (VP of Manufacturing) who is based in Boston, to continue to form a strong US-based team focusing primarily on North American consumers.
“It is a great pleasure to welcome a talent such as Yael to the team. I have no doubt she will be a key contributor to the success of our upcoming major VINIA® launch in the US.” Said Ilan Sobel, CEO of BioHarvest.
About BioHarvest Sciences Inc.
Based in Vancouver BC, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology. It is the first and only industrial-scale plant cell technology capable of producing the active plant ingredients without the necessity to grow the plant itself. The Company’s technology is non-GMO and has already been validated by VINIA®, the red grapes cells functional food/dietary supplement produced and sold by BioHarvest Sciences Inc. The Company plans to generate significant revenue within the global nutraceutical ingredients and dietary supplements market with VINIA® and other Super Fruit Nutraceutical products. Further, by adapting this technology to the Cannabis plant, and building adequate production capacity, BioHarvest Sciences Inc.’s objective is to become a leading supplier of Cannabis for both medicinal and legal recreational purposes. Visit: www.bioharvest.com.